Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

The China IPO Window is Open for Pharma Companies

publication date: Oct 2, 2009
In July, after a nine-month hiatus, the IPO window in China suddenly reopened. Who won the distinction of being first IPO out of the box? A middle-sized TCM company with an expertise in lozenges, Guilan Sanjin Pharmaceutical Company. Sanjin was anything but a one-shot phenomenon, because three other pharma-connected companies have followed in the two months since Sanjin made its debut, and each of them was also well received. Three more China pharmas are set to IPO on the new GEM exchange. The success of these offerings dispels, without a doubt, the myth that pharma IPOs are dead. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital